| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2020 | Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells | Chiang, ZC; Chiu, YK; Lee, CC; Hsu, NS; Tsou, YL; Chen, HS; Hsu, HR; Yang, TJ; Yang, AS ; Wang, AH | PloS one 15(9), e0239813 | | | |
| 2021 | SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection | Tsai, Tsung-Yu; Huang, Ming-Ting; Sung, Pei-Shan; Peng, Cheng-Yuan; Tao, Mi-Hua ; Yang, Hwai-I ; Chang, Wei-Chiao; Yang, An-Suei ; Yu, Chung-Ming; Lin, Ya-Ping; Bau, Ching-Yu; Huang, Chih-Jen; Pan, Mei-Hung; Wu, Chung-Yi ; Hsiao, Chwan-Deng ; Yeh, Yi-Hung; Duan, Shiteng; Paulson, James, C; Hsieh, Shie-Liang | Journal of Clinical Investigation 131(11), e141965 | | | |
| 2011 | Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. | Yang, FL; Yang, YL ; Liao, PC; Chou, JC; Tsai, KC; Yang, AS ; Sheu, F; Lin, TL; Hsieh, PF; Wang, JT; Hua, KF; Wu, SH | Journal of biological chemistry 286(24), 21041-21051 | | | |
| 2007 | Structure-Based Design and Synthesis of Highly Potent SARS-CoV 3CL Protease Inhibitors | Shao, Y. M.; Yang, W. B. ; Peng, H. P.; Hsu, M. F.; Tsai, K. C.; Kuo, T. H.; Wang, A. H. J. ; Liang, P. H. ; Lin, C. H. ; Yang, A. S. ; Wong, C. H. | ChemBioChem 8(14), 1654-1657 | | | |
| 2021 | Structure-based Development of Human Interleukin-1β-Specific Antibody That Simultaneously Inhibits Binding to Both IL-1RI and IL-1RAcP | Kuo, WC; Lee, CC; Chang, YW; Pang, W; Chen, HS; Hou, SC; Lo, SY; Yang, AS ; Wang, AH | Journal of molecular biology 433(4), 166766 | | | |
